Market Brief: Orthobiologics Market Will See Modest Growth By 2024, Stimulated By Growth Factors
Executive Summary
Global sales of orthobiologics products are expected to reach $2.8bn by 2024, a CAGR of 3.2%, led by the rising aging population and musculoskeletal disease.
You may also be interested in...
AAOS 2021: Digital Tools In Surgical Ecosystem, Software-Enabled Tech, Robots, Wearables, Sensors
At the live AAOS conference, exhibitors, including major orthopedics players, demoed digital innovations, software-enabled technologies, robotics and smart implants that are expected to create efficiencies in the surgical continuum and provide data to improve outcomes.
Edwards Lifesciences Mike Mussallem To Retire As CEO, Bernard Zovighian Named Successor
Mussallem’s retirement at age 70 does not come as a surprise to the Street, but analysts expect some headwinds for his successor Bernard Zovighian, who has been heading the firm’s transcatheter mitral and tricuspid valve repair business.
HLTH 2022: Neurotrack’s CEO Stresses Need For Three-Minute Digital Test To Detect Cognitive Decline Early
Neurotrack hopes to bring its three-minute digital cognitive assessment tool into primary care offices as part of the Medicare Annual Wellness visit.